Harmony Biosciences (HRMY)
Commercializes WAKIX for narcolepsy while developing next-generation pitolisant and rare-neurology therapies.
$40.71
vs last close−0.83 (−1.99%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 93.76% | 54.60M shares | |
|---|---|---|---|
| 336 holders · as of Jun 30, 2026 | |||
| Insiders | 0.09% | 53.3K shares | |
| 6 holders · as of Sep 18, 2026 | |||
| Strategic holders | 29.73% | 17.31M shares | |
| 4 holders · as of Feb 10, 2025 | |||
| Adds to | 123.58% | ||
58.24M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 123.58%; nothing is left for Other.
13F, as of Jun 30, 2026
336 holders · 54.60M shares · 52 new positions · 184 increased · 109 reduced · 36 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.10M | 12.20% | +31.9K | Aug 7, 2026 |
| FMR LLC | 3.57M | 6.14% | +416.5K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 2.88M | 4.95% | +166.1K | Aug 13, 2026 |
| American Century Companies Inc | 2.54M | 4.36% | +434.3K | Aug 12, 2026 |
| Dimensional Fund Advisors LP | 2.39M | 4.11% | +317.1K | Aug 11, 2026 |
| Vanguard Capital Management LLC | 2.11M | 3.61% | +2.7K | Aug 13, 2026 |
| LSV Asset Management | 2.06M | 3.54% | +36.1K | Aug 6, 2026 |
| State Street Corp | 1.86M | 3.19% | +75.0K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Marshman Fund Trust II | 10.60% | 6.05M | 13G | Feb 10, 2025 |
| BlackRock, Inc. | 10.10% | 5.77M | 13G | Apr 29, 2025 |
| FMR LLC | 5.40% | 3.11M | 13G | Feb 5, 2026 |
| Vanguard Portfolio Management | 5.08% | 2.94M | 13G | Jul 31, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 18, 2026 | Kumar Budurofficer: CHIEF MEDICAL OFFICER | Sale | 35,852 | $43.05 | 13,115 |
| Sep 17, 2026 | Kumar Budurofficer: CHIEF MEDICAL OFFICER | Sale | 800 | $43.00 | 13,115 |
| Sep 16, 2026 | Kumar Budurofficer: CHIEF MEDICAL OFFICER | Sale | 1,800 | $43.01 | 13,115 |
| Sep 8, 2026 | Kumar Budurofficer: CHIEF MEDICAL OFFICER | Sale · 3 lots | 28,454 | $42.96 | 13,115 |
| Sep 4, 2026 | Kumar Budurofficer: CHIEF MEDICAL OFFICER | Sale | 5,500 | $41.98 | 18,615 |
| Jan 26, 2026 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 3,746 | $37.15 | 24,521 |
| Jan 15, 2026 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 20,961 | $35.92 | 0 |
| Dec 12, 2025 | Jeffrey M. Daynodirector, officer: PRESIDENT, CEO | Sale | 5,933 | $40.11 | 0 |
| Dec 5, 2025 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 20,000 | $39.54 | 0 |
| Nov 21, 2025 | Sandip Kapadiaofficer: CHIEF FINANCIAL OFFICER | Sale | 3,427 | $35.00 | 0 |
House and Senate disclosures
Not reported.